Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

BENZOCAINE AND MENTHOL

Active
SPE2DP-26-T-4334Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract specifies the procurement of Benzocaine and Menthol Lozenge, marketed as CEPACOL EXTRA STRENGTH SORE THROAT HONEY LEMON LOZENGES, with each lozenge containing 15mg of benzocaine and 2.6mg of menthol, packaged in quantities of 16 lozenges per unit. The product must be stored at 20-25°C (68-77°F) and protected from humidity. Packaging must comply with commercial standards as outlined in the procurement document, requiring each unit to be sealed in a container that prevents damage or breakage, and all units must be packed in commercial shipping containers suitable for safe delivery via common carrier at the lowest cost to the designated delivery point. Medical Marking Standard No. 1 (MMS No. 1) is mandatory for labeling, replacing all prior references to MIL-STD-129, and must be followed exactly. The item has a non-extendable shelf life of 36 months and is classified as a TYPE I (CODE Q) item under RS020 requirements. The supplier is Reckitt Benckiser LLC with NDC63824-0732-16, and the NSN is 6505017081449. A total of three packaging groups (PG) are ordered, with a unit price of $3.00 and a total price of $9.00, to be delivered FOB destination within 20 days of contract award. Delivery is to Fort Bliss, Texas, and must be shipped by traceable means, excluding parcel post. The required delivery date is July 29, 2026, and all packaging and marking must adhere to DLA’s packaging and medical marking directives. The procurement is part of a federal acquisition under DoD authority, with technical and quality requirements governed by the DLA Master List and controlled by the solicitation's effective revision date.

General Info

Procurement of 3 packaging groups of CEPACOL lozenges, 16 units each, 15mg benzocaine, 2.6mg menthol, FOB Fort Bliss, delivery by July 29, 2026.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325411 - Medicinal and Botanical ManufacturingView NAICS

Place of Performance

21287 LIGHT INFANTRY AVENUE, FORT BLISS, TX, 79918-2527, US

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-4334.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts
JAMES FOGGIE
contact@example.gov
+1 (555) 000-0000

Full Description

Show more
BENZOCAINE AND MENTHOL LOZENGE
Benzocaine and Menthol Lozenge CEPACOL EXTRA STRENGTH SORE THROAT HONEY LEMON LOZENGES. BENZOCAINE 15MG, MENTHOL 2.6MG ORAL PAIN RELIEVERS, PACKAGE OF 16. STORE AT 20-25 C (68-77 F).PROTECT CONTENTS FROM HUMIDITY.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS (IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
RECKITT BENCKISER LLC 0MWS8 P/N NDC638240732-16 RB HEALTH US LLC 860J1 P/N NDC63824-0732-16
SPE2DP-26-T-4334
SECTION B
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017631635 0001 PG 3.000
NSN/MATERIAL:6505017081449
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:U
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
SPE2DP-26-T-4334
SECTION B
PR: 7017631635 PRLI: 0001 CONT’D
BULK BREAK POINT:
W8001Z
0142 CS BN CO A COMPOSITE
1AD SUSTAINMENT BRIGADE SSA
21287 LIGHT INFANTRY AVENUE
FORT BLISS TX 79918-2527
US
SHIP BY TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W8001Z
0142 CS BN CO A COMPOSITE
1AD SUSTAINMENT BRIGADE SSA
21287 LIGHT INFANTRY AVENUE
FORT BLISS TX 79918-2527
US
MARKFOR
W8001Z
0142 CS BN CO A COMPOSITE
1AD SUSTAINMENT BRIGADE SSA
21287 LIGHT INFANTRY AVENUE
FORT BLISS TX 79918-2527
US
M/F: (TCN) W8001Z62050038
RDD: 219
PROJ: TP 3
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 12
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:07/29/2026
SPE2DP-26-T-4334 NSN/Part Number: 6505-01-708-1449 Quantity: 3 PG Purchase Request: 7017631635QTY: 3 Delivery: 20 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325411
New
DIBBS
PHENYLEPHRINE HYDROThe contract specifies the procurement of Phenylephrine Hydrochloride Ophthalmic Solution USP 2.5% in 10 mL sterile, aqueous, topical bottles manufactured by Bausch & Lomb Americas Inc. with NDC 82260-0102-10, to be delivered in a quantity of six bottles under solicitation SPE2DP-26-T-4342. The product must be stored at 2°C to 25°C (36°F to 77°F) and packaged in sealed unit containers that protect against damage, with all outer shipping containers meeting commercial standards for safe transport by common carrier at the lowest cost to the designated destination in Williamsburg, VA. Packaging and marking must comply with Medical Marking Standard No. 1, replacing all references to MIL-STD-129, and palletization must follow DLA Packaging Requirements for Procurement. The item has a non-extendable shelf life of 24 months as a TYPE I (CODE M) product and must be labeled accordingly. The solution is contained in opaque white LDPE bottles with LLDPE dropper tips and red caps, and the entire shipment must be delivered FOB destination within five days of the order. Shipment must be sent by the fastest traceable means; parcel post is prohibited. Delivery is required by April 15, 2026, with inspection and acceptance occurring at the destination point. The National Stock Number is 6505017090360 and the purchase request number is 7016297029. The item is regulated by the FDA, requiring a referral to the product specialist through EBS with full bidder and manufacturer details. All technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, with the revision in effect on the solicitation issue date controlling. Contract-specific identifiers, including CLIN, pricing, and unit of issue, are structured under the DoD authorized unit of issue system, and all documentation must reflect current DLA standards for marking, packaging, and logistics. The point of contact for inquiries is James Mariani of the Department of Defense Medical Supply Chain.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
VERAPAMIL HYDROCHLORIDVerapamil hydrochloride injection is a 5 mg per 2 mL solution packaged in 2 mL single-dose glass fliptop vials, supplied in packs of 25, and is preservative-free for intravenous use only. The product must be protected from light and stored at controlled room temperature between 20 to 25°C (68 to 77°F), conforming to USP standards. It has a non-extendable shelf life of 24 months from the date of manufacture, and no more than four months may have elapsed between manufacture and delivery to the government. The item is identified by NSN 6505-01-738-0226 and is subject to stringent technical and quality requirements as defined in the DLA Master List, with packaging and handling governed by DLA procurement standards. Government identification must be removed from non-accepted supplies, and covered defense information provisions apply. The solicitation, issued under SPE2DP-26-T-4330 on July 28, 2026, with a response deadline of August 3, 2026, is for a federal procurement through the Department of Defense’s Medical Supply Chain PHARM FSA, with delivery required within five days of award, and the point of contact is Daniel Porter at daniel.porter@dla.mil.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
DIETARY SUPPLEMENT, THEThe product is an unflavored therapeutic dietary supplement in powder form, packaged in 80-gram units, with each packet reconstituted to yield 8 to 10 ounces of liquid. It is lactose-free and supplied in packages containing six individual units, with a unit of issue defined as a package. Each package must have an 18-month shelf life from the date of manufacture, and no more than three months may elapse between the manufacture date and delivery to the government. Packaging must comply with commercial standards as specified, using sealed unit containers to protect contents from damage, and exterior shipping containers must ensure safe, cost-effective delivery via common carriers. Labeling and marking must follow Medical Marking Standard No. 1, superseding MIL-STD-129, and palletization must adhere to DLA Packaging Requirements for Procurement. All technical and quality requirements from the DLA Master List take precedence over ASTM D3951. The item is subject to firm fixed pricing with zero variance in quantity, inspection and acceptance occur at destination, and delivery is due within 35 days after order date. Shipping must be via traceable freight methods only, not parcel post, with specified delivery addresses for two distinct locations. The contract includes clauses related to veteran employment reporting, sustainable product procurement, and Wide Area Workflow payment processing. The National Stock Number is 8940-01-317-9838, and the solicitation number is SPE2DP-26-Q-0125.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 8 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325411
New
DIBBS
SUMATRIPTAN SUCCINATESumatriptan Succinate Tablets, 100 mg in bottles of nine tablets, are procured under contract SPE2DP-26-T-4339 for acute treatment of migraines with or without aura in adults. The product must be stored at 20 to 25°C (68 to 77°F), protected from light, and carries a non-extendable 24-month shelf life as a Type I (Code M) item. Packaging and labeling must comply with MIL-STD-2073-1E, MIL-STD-129, and the latest Medical Marking Standard No. 1, with palletization following DLA Packaging Requirements. The item is regulated by the FDA and requires confirmation via EBS referral before award. Delivery is FOB destination within five days, with zero quantity variance allowed, and inspection and acceptance occur at the delivery point. Three separate CLINs specify delivery to APO AE 09094-3219 and JBER AK 99506, with total quantities of one bottle each for two entries and five bottles for the third, all under the same NSN 6505017278704. The contract references DLA technical and quality requirements, including RD003 for covered defense information, and mandates adherence to specified marking and shipping protocols. The solicitation was posted on July 28, 2026, with a response deadline of August 3, 2026, and required delivery dates range from July 29 to July 30, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
TRANEXAMIC ACID INJECTTranexamic acid injection is a sterile, single-dose, unpreserved intravenous solution containing 10 mg of tranexamic acid USP per mL, formulated in 100 mL with 7 mg of sodium chloride USP in water for injection USP, with a pH range of 6.5 to 8.0. Each unit is supplied in a polymer bag sealed with a twist-off port and oversealed in an aluminum pouch, containing a total of 1000 mg of tranexamic acid. The product must be stored at 20°C to 25°C (68°F to 77°F), with permissible excursions between 15°C and 30°C (59°F to 86°F), and has a non-extendable shelf life of 24 months. Each case contains ten single-dose bags, and the item is identified by NSN 6505-01-694-2815 and NDC 51754-0108-03, manufactured by EXELA PHARMA SCIENCES LLC. Packaging and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must meet DLA packaging requirements for procurement, including palletization and protective measures to ensure safe transport. The contract specifies delivery to Fort Bragg, NC, within 20 days of award, with FOB destination terms, zero quantity variance, and inspection and acceptance occurring at the delivery point. The item is subject to defense information coverage requirements and must be shipped via traceable means, excluding parcel post. The solicitation number is SPE2DP-26-T-4321, with a response deadline of August 3, 2026, and the original required delivery date is July 29, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
CALCIUM CARBONATE TABLCalcium carbonate tablets, each containing 500 mg of active ingredient, are intended for the relief of heartburn, acid indigestion, sour stomach, and upset stomach. The product is peppermint-flavored, chewable, and supplied in a quantity of four bundles totaling 150 tablets per bundle. The item has a non-extendable shelf life of 36 months and must be stored at room temperature in a tightly closed container. Packaging and labeling must comply with DLA procurement standards, including MIL-STD-2073-1E for packaging and Medical Marking Standard No. 1, which supersedes MIL-STD-129. The product is subject to tailored higher-level quality requirements and is classified as a Type I (Code Q) item with strict compliance to technical and quality specifications outlined in the DLA Master List. Delivery is FOB destination, with a required delivery date of July 28, 2026, and a 20-day lead time. Shipment must be traceable, excluding parcel post, and addressed to Fort Bragg, North Carolina. The NSN is 6505-01-725-1756, and the contract solicitation number is SPE2DP-26-T-4303, issued by the Department of Defense under NAICS code 325411.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
Supply of Hazardous Medical Material with Full Regulatory ComplianceThe contract concerns the supply and delivery of a hazardous medical item identified by NSN 6510-01-458-6294, requiring strict adherence to OSHA, DFARS, and military-specific packaging and labeling protocols. All proposed submissions must include complete Safety Data Sheets prior to award, and the item must comply with defined shelf-life limitations and marking requirements to ensure safe handling and traceability throughout the supply chain. Performance is designated for Annville, Pennsylvania, with the entire transaction governed under the Department of Defense’s Medical Supply Chain MD Surg FSF. The solicitation, classified as a subcontract, is open for responses until August 3, 2026, with a NAICS code of 325411 indicating manufacturing of pharmaceutical and biological products. Compliance with all regulatory and procedural requirements is mandatory for eligibility.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

2 days ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
BENZOCAINE AND MENTHOLThe contract is for the procurement of Benzocaine and Menthol Lozenge CEPACOL EXTRA STRENGTH SORE THROAT HONEY LEMON LOZENGES, each containing 15 mg benzocaine and 2.6 mg menthol, packaged in quantities of 16 lozenges per unit. The product must be stored at 20–25°C (68–77°F) and protected from humidity. Deliveries are specified under two CLINs for a total of 31 packages, with a unit price of $1.82 per package, resulting in a total estimated contract value of $56.42. The items are to be delivered FOB destination, with delivery required by July 28–29, 2026, to Fort Bragg, North Carolina, where inspection and acceptance also occur. Packaging must comply with commercial standards as defined in the procurement document, with each unit sealed in a container that prevents damage or breakage, and all units packed in exterior shipping containers suitable for safe, cost-effective transport by common carrier. Marking must adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and palletization must follow DLA’s RP001 packaging requirements. Preservation and packaging data are structured per MIL-STD-2073-1E, with specific placeholders for preservation methods, wrapping materials, and unit containment. The NSN for the item is 6505017081449, and the product carries a non-extendable shelf life of 36 months as a TYPE I (CODE Q) item. The contractor, Reckitt Benckiser LLC, must ensure all materials are marked and documented in accordance with DLA’s standards and submit invoices electronically through WAWF. The solicitation number is SPE2DP-26-T-4285, issued by DLA Troop Support under the Department of Defense, with a response deadline of August 3, 2026, and submission must be made via DIBBS. The contract incorporates numerous FAR and DFARS clauses covering cybersecurity, hazardous materials, trafficking in persons, employment eligibility, sustainable products, inspection, default, and safeguarding of covered defense information. Compliance with the Hazard Communication Standard is required, and contractors must provide hazard warning labels for any applicable materials. No options or extensions are defined, and the contract
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
SUMATRIPTAN SUCCINATESumatriptan Succinate Tablets, 100mg in bottles of nine tablets, are being procured under solicitation SPE2DP-26-T-4284 by the Department of Defense’s Medical Supply Chain Pharmaceutical FSA for delivery to Joint Base Elmendorf-Richardson in Alaska. The item is regulated by the FDA and must be stored at 20 to 25°C (68 to 77°F), protected from light, with a non-extendable shelf life of 24 months as a Type I (Code M) item. The contract specifies delivery within five days of order, FOB destination, with inspection and acceptance occurring at the delivery point. Packaging must adhere to MIL-STD-2073-1E and be palletized per DLA’s RP001 requirements, with labeling and marking fully compliant with MIL-STD-129 and the latest Medical Marking Standard No. 1, including mandatory 2D Data Matrix barcodes. The unit of issue is a bottle, and the sole line item quantity is one bottle, with an estimated value of $18.77 based on prior procurement history. The NSN is 6505-01-727-8704, and the manufacturers listed are Mylan Pharmaceuticals Inc. and Golden State Medical Supply, Inc., with respective NDC codes. All supplies must be free of government identification upon rejection and comply with covered defense information requirements under RD003 and safeguards for cyber incident reporting under 252.204-7012. Invoicing must be submitted through Wide Area WorkFlow, and contractors must adhere to all applicable FAR clauses including 52.213-4 for simplified acquisitions, 52.216-1 with Alternate I for contract type, and provisions on hazardous materials, trafficking in persons, employment eligibility, and sustainable products. Offerors must complete required representations in Section K regarding small business status, UEI and CAGE codes, and compliance with prohibitions on covered telecommunications equipment, though no completed responses are provided in the solicitation. Proposals must be submitted electronically via DIBBS by August 3, 2026, using SF-18, with no page limits specified. The contract includes no option quantities, and the place of performance is fixed at the specified JBER address.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
KETOROLAC TROMETHAMINEKETOROLAC TROMETHAMINE INJECTION, USP 15 MG PER ML in prefilled syringes, packaged 24 per unit, is being procured under solicitation SPE2DP-26-T-4270 with a required delivery of five days to Fort Bragg, North Carolina. The product must comply with DLA’s Master List of Technical and Quality Requirements including shelf-life standards of 24 months, non-extendable, and packaging guidelines as per Medical Marking Standard No. 1, which supersedes MIL-STD-129. All packaging must protect against damage, be commercially sealed, and meet export shipping requirements where applicable. The item is labeled with NDC 76045-0107-10 and is manufactured by FRESENIUS KABI, LLC. The supply must adhere to federal hazardous material handling regulations under OSHA’s revised Hazard Communication Standard effective June 1, 2015, requiring submission of Safety Data Sheets and compliant labeling in accordance with 29 C.F.R. 1910.1200 prior to award. Employee training on these new safety standards is mandatory. Shipments must be sent via the fastest traceable means, excluding parcel post, and palletization must follow DLA’s RP001 packaging requirements. The contract specifies a zero percent quantity variance, acceptance at destination, and delivery to a secure government facility at Fort Bragg with strict marking and documentation protocols. The required delivery date is July 27, 2026, and all packaging and labeling must reflect current DLA and federal compliance standards without exception.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
MORPHINE SULFATE INMorphine Sulfate Injection 10 mg/mL in a 1x10 NEXJECT configuration, designated as a DEA Schedule II controlled substance, is being procured under solicitation SPE2DP-26-T-4277 with a total quantity of 3 packages, each containing 10 units. The item has a non-extendable shelf life of 18 months and must be stored at controlled room temperature. Packaging and labeling must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all packaging must meet DLA’s procurement requirements and be commercial in nature, ensuring protection against damage during transport. The product is regulated by the FDA and requires confirmation through EBS referral by the contracting official prior to award. The manufacturer is Pfizer Inc., with NDC 00409-1893-23, and delivery is required FOB destination within five days of award to the specified address at Joint Base Elmendorf-Richardson, Alaska. The unit of issue is a package of 10, and no quantity variance is permitted. Transportation logistics are governed by DLA procedural notes C19 and C20, and the item must be marked and palletized according to DLA standards. All technical and quality requirements referenced by R or I numbers are incorporated from the DLA Master List, with the applicable revision controlled by the solicitation issue date.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
Chemical Detection Chip ManufacturingThe contract mandates the manufacture of chemical detection chips designed to detect ammonia concentrations within a precise range of 2.0 to 50.0 parts per million, with each unit incorporating ten reagent-filled capillaries calibrated during production to ensure accuracy and consistency. The chips must be engineered to maintain performance integrity over a two-year shelf life under standard storage conditions, requiring strict quality control throughout the fabrication process to guarantee reliability and longevity. Production must adhere to industry standards for analytical sensor fabrication, with calibration protocols documented and verified to meet the specified detection thresholds. The solicitation, issued under NAICS code 325411 for chemical and chemical products manufacturing, is structured as a subcontract within the Department of Defense’s Medical Supply Chain FSH framework. Performance is required at the APO location with ZIP code 09094-3219, indicating deployment to military or overseas operational sites where rapid, portable ammonia detection is critical for safety and environmental monitoring. The response deadline is set for July 30, 2026, with the solicitation posted on July 23, 2026, allowing a seven-day window for submissions through the DIBBS platform. All deliverables must be fully compliant with defense procurement technical and logistical requirements.
MEDICAL SUPPLY CHAIIN FSH

POSTED

5 days ago

DEADLINE

in 1 day
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 424210
New
DIBBS
SUNSCREEN PREPARATIONThe contract is for a topical sunscreen preparation containing 4.5% titanium dioxide and 4% zinc oxide with an SPF of 50, designed for outdoor use and labeled as sweat and water-resistant for 80 minutes, hypoallergenic, oil-free, PABA-free, and biodegradable. Each unit of issue is a package containing 24 tubes of 3 ounces, with a total shelf life of 24 months and a minimum of 21 months remaining at time of delivery to the first government activity. Storage must be maintained between 15°C and 30°C (59°F and 86°F) in a cool, dry environment. The product is regulated by the FDA and must comply with all DLA Master List of Technical and Quality Requirements, which take precedence over commercial standards like ASTM D3951. Packaging must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and all units must be sealed and shipped in commercially appropriate containers that ensure safe delivery via common carrier at the lowest cost to the specified delivery points. Palletization must follow DLA packaging requirements, and shipment must occur by the fastest traceable means, excluding parcel post. The material is not classified as hazardous under FED-STD-313, so commercial packaging per ASTM D3951 applies unless overridden by stricter DLA requirements. Three separate delivery line items exist, totaling four pallets, with delivery addresses at military installations in Massachusetts, North Carolina, and aboard the USS Gridley via FPO. All deliveries are FOB destination with zero quantity variance, inspected and accepted at the delivery point, with required delivery dates ranging from July 29 to July 30, 2026. The solicitation number is SPE2DP-26-T-4340, with a response deadline of August 3, 2026.
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
ZINC OXIDE OINTMENTZINC OXIDE OINTMENT USP, containing 20% zinc oxide in a 1-ounce collapsible tube weighing 28.35 grams, is procured as a topical skin protectant under contract SPE2DP-26-T-4335. The item is regulated by the FDA and must comply with all applicable DLA Master List of Technical and Quality Requirements, including packaging standards per MIL-STD-129 and DLA Packaging Requirements for Procurement RP001. The product requires storage at controlled room temperature not exceeding 30°C (86°F) and has a non-extendable shelf life of 36 months as a TYPE I (CODE Q) item. All packaging must be marked in accordance with the latest Medical Marking Standard No. 1 and labeled with the NDC number 67777-0223-11. The unit of issue is the tube (TU), and no variance in quantity is permitted. The contract includes two line items totaling 14 tubes: 10 tubes delivered to a location in Richmond, Virginia, and 4 tubes delivered to Melrose, Massachusetts. Both deliveries are FOB destination with a five-day delivery window and must be shipped via traceable means—parcel post is prohibited. Packaging must adhere to ASTM D3951 if not classified as hazardous under FED-STD-313, but DLA requirements override any conflicting standards. Palletization follows RP001 guidelines, and all shipments must include proper government identification markings. The original required delivery dates are July 29, 2026, and July 30, 2026, respectively. The contract specifies a unit price of $1.00 per tube with no total price variation, and it is managed by the Department of Defense’s Medical Supply Chain Pharm FSA, with James McCullough as the primary point of contact.
Pharmaceutical Preparation Manufacturing

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
ZOLMITRIPTAN TABLETZolmitriptan tablets, 2.5 mg film-coated, are supplied in blister packs containing six tablets per package, with the unit of issue defined as a package of six units. The product must be stored at controlled room temperature and marked in accordance with the latest edition of the Medical Marking Standard No. 1, adhering to DLA packaging requirements and technical quality standards as outlined in the DLA Master List of Technical and Quality Requirements. The item is classified as a Type I (Code Q) drug with a non-extendable shelf life of 36 months, and all supplies must comply with removal of government identification if not accepted, with potential application of Covered Defense Information protocols. The contract specifies two manufacturer part numbers—NDC71626-0101-06 from Medstone Pharma LLC and NDC60846-0130-30 from Amneal Pharmaceuticals of New York, LLC—both subject to FDA regulation and requiring prior confirmation via EBS referral by the contracting official. The delivery instruction requires FOB destination within 20 days, with no variance allowed in quantity, inspection and acceptance occurring at the delivery point, and packaging must meet MIL-STD-2073-1E standards. The contract, issued under solicitation SPE2DP-26-T-4332, has a posted date of July 28, 2026, and a response deadline of August 3, 2026, with three packages totaling 18 tablets ordered at $3.00 per package. The item is linked to NSN 6505015232352 and classified under NAICS code 325412 for pharmaceutical manufacturing.
Pharmaceutical Preparation Manufacturing

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 423450
New
DIBBS
ATROPINE SULFATE INAtropine Sulfate Injection, USP, is a sterile, nonpyrogenic, preservative-free, and non-DEHP product supplied in a 5 mL single-dose syringe with a 20-gauge by 1.5-inch protected needle featuring a male Luer lock adapter. Each milliliter contains 0.1 mg of atropine sulfate monohydrate and 9 mg of sodium chloride, resulting in a total of 0.5 mg of atropine per syringe. The medication is indicated for subcutaneous, intramuscular, or intravenous administration and is labeled RX only. The product must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F) and has a non-extendable shelf life of 24 months. Packaging and labeling must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and all DLA Master List of Technical and Quality Requirements take precedence over commercial packaging standards. The product is regulated by the FDA and is supplied by Pfizer Inc with NDC code 00409-4910-34. The contract, issued under solicitation number SPE2DP-26-T-4325, requires delivery of one pallet (PG) containing ten units to Fort Bragg, North Carolina, within 20 days of order placement, FOB destination. No quantity variance is permitted, and inspection and acceptance occur at the delivery point. The material is not classified as hazardous under FED-STD-313 and must be commercially packaged in accordance with ASTM D3951, unless overridden by DLA requirements. All packaging must be marked and labeled per DLA specifications, palletized as per RP001, and shipped via traceable means, excluding parcel post. The delivery is mandated for July 29, 2026, with the contract awarded to the Department of Defense, Medical Supply Chain Pharm FSA, and all technical, quality, and packaging specifications are governed by the DLA Master List in effect on the solicitation issue date. A referral must be sent via EBS to confirm bidder and manufacturer details prior to award.
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 423450
New
DIBBS
LIDOCAINE HYDROCHLOLidocaine Hydrochloride and Epinephrine, USP, is a parenteral injectable pharmaceutical product containing a 2 percent concentration of lidocaine hydrochloride and a 1:50,000 dilution of epinephrine bitartrate, supplied in 1.7 mL single-dose cartridges. Each unit of issue consists of a package of 50 cartridges, organized in five blisters of ten per cardboard box. The product must be stored at controlled room temperature below 25°C (77°F), protected from light, and must not be frozen. It is regulated by the FDA and has a non-extendable shelf life of 18 months as a Type I (Code K) item. Packaging and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must ensure the product is sealed, protected from damage, and shipped in suitable commercial containers to guarantee safe delivery. Technical and quality requirements referenced in the document are governed by the DLA Master List of Technical and Quality Requirements, with revisions controlled based on solicitation or award date depending on acquisition type. This procurement is issued under Solicitation Number SPE2DP-26-T-4333 by the Department of Defense’s Medical Supply Chain Pharm FSA. One pack (PG) of 50 cartridges is required, with a delivery requirement of five days after award, delivered FOB destination to JBER, Alaska. The NSN is 6505-01-576-2767 and the purchase request number is 7017631646. The product must be supplied by an approved manufacturer with part number NDC66312-0181-16 or equivalent, and shipment must adhere to all DLA packaging standards, including commercial packaging for medical items and specific marking requirements. No quantity variance is permitted, and inspection and acceptance occur at the destination. The required delivery date is July 29, 2026, and the response deadline for the solicitation is August 3, 2026. The contracting officer must submit a referral in EBS for confirmation, including manufacturer and bidder details. Transportation and delivery logistics are governed by DLA procedural notes C19 and C20, with the point of contact for inquiries being Timothy McCauley.
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
RINGER'S INJECTION, LACRINGER'S INJECTION, LACTATED, USP, 1000ML in packs of 12 units per case, is being procured under contract SPE2DP-26-T-4338 with a total quantity of 3 cases, each containing 12 units, for delivery to Bogalusa, LA within five days under FOB destination terms. The product must be packaged in sealed unit containers that protect against damage and shipped in commercial exterior containers suitable for safe transport by common carrier at the lowest cost, conforming to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The item, manufactured by B. BROWN MEDICAL INC with NDC 00264-7750-00, has a non-extendable shelf life of 30 months and must be stored at room temperature (25°C) with brief exposure up to 40°C permitted; freezing and excessive heat must be avoided. All packaging and labeling must adhere to the latest version of the Medical Marking Standard No. 1, available through DLA Troop Support, and technical and quality requirements referenced by R or I numbers are governed by the DLA Master List in effect at the solicitation or award date. The contract specifies zero variance in quantity, inspection and acceptance occur at delivery point, and government identification must be removed from non-accepted supplies. The FDA regulates this drug, requiring buyer referral via EBS to the product specialist, including manufacturer and bidder details. The purchase is under the DoD unit of issue system, and procurement falls under NAICS 325412.
Pharmaceutical Preparation Manufacturing

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
EMOLLIENT LOTIONThe contract specifies the procurement of 2 bottles of Emollient Lotion, each containing 240 mL (8 FL OZ), packaged in a non-sterile bottle with a dispenser cap. The lotion must be an oil-in-water or water-in-oil emulsion containing a minimum of water, a suitable oil, an emulsifier, and a preservative, with additional compliant ingredients such as stabilizers, thickening agents, emollients, surfactants, humectants, colorants, and fragrances permitted in sufficient quantities. It must maintain a pH between 5.0 and 8.1 and exhibit a viscosity of 10,000 to 20,000 CPS at 25°C when measured with a Brookfield Viscometer Model LVT using Spindle No. 13 at 6 RPM. The product is regulated by the FDA and must be stored at controlled room temperature. Packaging and marking must comply with the latest Medical Marking Standard No. 1 and MIL-STD-129, with commercial packaging adhering to ASTM D3951 unless superseded by stricter DLA requirements. The unit of issue is a bottle (BT), and delivery is required FOB destination within 20 days of contract award to a military installation at Fort Bliss, Texas. No quantity variance is permitted, and inspection and acceptance occur at the destination. Traceable shipping methods are mandatory, and parcel post is prohibited. The contract reference number is SPE2DP-26-T-4329, with a required delivery date of July 29, 2026, and the product is identified by NSN 6508-01-019-7181. The supplier must meet all technical and quality requirements outlined in the DLA Master List of Technical and Quality Requirements.
Pharmaceutical Preparation Manufacturing

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325620
New
DIBBS
SUNSCREEN AND INSECT RThe contract specifies the procurement of a 4 oz spray bottle containing SPF 30 sunscreen and an all-natural insect repellent, packaged in units of 12 per package, with a non-extendable shelf life of 36 months as required for a Type I (Code Q) item. All packaging, marking, and labeling must comply with the Medical Marking Standard No. 1, superseding MIL-STD-129, and must ensure the product is protected from damage during transit while meeting commercial packaging standards. The item is classified as flammable/combustible, triggering adherence to Hazard Communication Standard requirements under 29 C.F.R. 1910.1200, which mandates submission of Safety Data Sheets and compliant labels prior to award, along with employee training on hazard communication protocols. The product must be delivered FOB destination within 20 days of contract award, with no tolerance for quantity variance, and must be shipped via traceable means excluding parcel post to the delivery location at Fort Bragg, North Carolina. Packaging and palletization must follow DLA’s official procurement standards, and all technical and quality requirements referenced by R or I numbers are binding as defined in the DLA Master List. The contract number is SPE2DP-26-T-4326, the NSN is 6505-01-600-3398, and the required delivery date is July 29, 2026.
Toilet Preparation Manufacturing

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details
NAICS: 423450
New
DIBBS
TOLNAFTATE CREAMTolnaftate Cream, USP, is a 1% topical antifungal cream supplied in tubes containing 15 grams each, with the unit of issue being a tube (TU). The product has a total shelf life of 36 months, and at the time of receipt by the first government activity, there must be a minimum of 31 months of remaining shelf life. It must be stored at controlled room temperature between 20-25°C (68-77°F), with short-term excursions allowed between 15-30°C (59-86°F) in accordance with USP standards. The cream is manufactured by Taro Pharmaceuticals U.S.A., Inc., with NDC 51672-2020-01, and is regulated by the FDA. All technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, with specific references to RA001, RP001, RQ001, RS020, and RS001, which mandate compliance with FDA and DoD packaging, labeling, and shelf-life protocols. The product must be packaged in accordance with Commercial Packaging Standards as specified in the procurement document, with each unit sealed in a protective container and shipped in suitable exterior containers to ensure safe delivery via commercial carrier at the lowest rate to the designated destination. Packaging and marking must adhere strictly to Medical Marking Standard No. 1, superseding MIL-STD-129, and all labels must include required government identifiers. The shipment of 20 tubes is to be delivered FOB destination within 20 days, with no quantity variance permitted. Transportation must be via traceable means, excluding parcel post, and the item is to be delivered to the specified location in Bogalusa, Louisiana. The contract requires confirmation through EBS referral to the product specialist, ensuring proper vendor and manufacturer validation prior to award, and all documentation must comply with DLA’s acquisition and logistics directives, including palletization and hazardous material standards where applicable.
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

about 8 hours ago

DEADLINE

in 6 days
View Details